These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 27835059

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells.
    Sakakibara F, Hotta N, Koh N, Sakamoto N.
    Diabetes; 1993 Nov; 42(11):1594-600. PubMed ID: 8405700
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.
    Steele JW, Faulds D, Goa KL.
    Drugs Aging; 1993 Nov; 3(6):532-55. PubMed ID: 8312678
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
    Ando H, Takamura T, Nagai Y, Kaneko S, Kanazawa University Multicenter Diabetes Study Group.
    J Diabetes Complications; 2006 Nov; 20(6):367-70. PubMed ID: 17070440
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Osmotic expression of aldose reductase in retinal pigment epithelial cells: involvement of NFAT5.
    Winges A, Garcia TB, Prager P, Wiedemann P, Kohen L, Bringmann A, Hollborn M.
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2387-2400. PubMed ID: 27628063
    [Abstract] [Full Text] [Related]

  • 39. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes.
    Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T, Tanaka Y, Kawamori R.
    Endocr J; 2009 Dec; 56(1):149-56. PubMed ID: 18997444
    [Abstract] [Full Text] [Related]

  • 40. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.
    Amano S, Yamagishi Si, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M.
    Biochem Biophys Res Commun; 2002 Nov 29; 299(2):183-8. PubMed ID: 12437967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.